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Background. Recently, it has been proposed that ﬁbromyalgia (FM), a chronic widespread pain syndrome, results from overactive
endogenous excitatory pain mechanisms. Experimental studies using temporal summation paradigms have conﬁrmed this
hypothesis but have included small samples of patients, prompting our group to perform a large-scale study. Methods.S e v e n t y -
two female FM patients and 39 healthy females participated in the study. The temporal summation test consisted of a 2-minute
continuous and constant heat pulse administered with a thermode on the participants’ left forearm. Experimental temperature
was set at a value individually predetermined to induce a 50/100 pain rating. Results.R e l a t i v et oc o n t r o l s ,F Mp a t i e n t sh a dl o w e r
thermal pain thresholds and lower temporal summation of pain. However, 37 FM patients required experimental temperatures
lower than the minimal temperature used in controls (45◦C). Nevertheless, temporal summation was not increased in the other
FM subgroup, relative to controls, despite equivalent experimental temperatures. Discussion. Our results suggest that temporal
summation of pain is normal, rather than increased, in a large proportion of FM patients. Future studies on temporal summation
inFMwillneedtobecarefulsincesomeFMpatientsrequireabnormallylowexperimentaltemperaturesthatmayconfoundresults
and make necessary to separate patients into subgroups.
1.Introduction
Fibromyalgia (FM) is deﬁned by widespread chronic mus-
culoskeletal pain [1, 2], despite the absence of a clinically
demonstrable nociceptive cause. Although FM leads to
substantial social, economic, and health consequences, the
pathophysiology of the disorder remains poorly character-
ized.Inthelastdecade,theuseofpsychophysicalandelectro-
physiological procedures has produced evidence suggesting
an implication of the central nervous system in ﬁbromyalgia.
Moreprecisely,ithasbeenproposedthatFMmayresultfrom
overactive endogenous excitatory pain mechanisms [3].
The temporal summation paradigm is the experimental
model the most frequently used in humans to study endoge-
nousexcitatorypainmechanisms(e.g.,centralsensitization).
Temporal summation results in an ampliﬁcation of pain
perception following repeated or continuous administration
of constant noxious stimuli [4, 5]. Temporal summation of
pain is thought to reﬂect the progressive enhancement of C-
ﬁber-evoked responses of dorsal horn neurons (windup) and
seems to be dependent on N-methyl-D-aspartate (NMDA)
receptor mechanisms in both animals [6] and humans [7].
In human experimental settings, temporal summation is
usually elicited using phasic repetitive pain stimuli admin-
istered at short interstimulus intervals (≥0.3Hz) [8–10]o r
continuous tonic stimuli [11–13]. Over the last decades,
numerous studies using repetitive (thermal and mechanical)
noxious stimuli have repeatedly shown that temporal sum-
mation eﬀects are more pronounced in FM patients, relative
tohealthycontrols[14–17],stronglysuggestingthatFMisan2 Pain Research and Treatment
Table 1: Clinical and psychophysical diﬀerences between ﬁbromyalgia patients and healthy controls.
Variable FM
(n = 72)
<45◦C
(n = 37)
>45◦C
(n = 35)
HC
(n = 39)
Statistics
(2 groups)
Statistics
(3 groups)
Age 47.6
(9.8)
44.8
(9.5)
F = 2.1;
P = 0.147
Menstrual cycle Yes, 27;
no, 45
Yes, 18;
no, 18∗
χ2 = 2.7;
P = 0.259
Antidepressants Yes, 12;
No, 24∗
Yes, 15;
No, 20
χ2 = 0.7;
P = 0.409
Anticonvulsants Yes, 9;
No, 25∗
Yes, 8;
No, 27
χ2 = 0.1;
P = 0.728
FIQ total score 58.1 ±15.35 6 .0 ±13.3 F = 0.4;
P = 0.549
FIQ pain item 7.1 ±2.27 .0 ±1.7 F = 0.1;
P = 0.795
Pain rating at
time 0 (%) 50.1 ±24.24 8 .6 ±25.35 1 .7 ±23.45 0 .4 ±24.7 F = 0.003;
P = 0.954
F = 0.1;
P = 0.862
TPTs (◦C) 39.9
◦C ±3.73 8 .6 ±2.54 1 .3 ±4.14 2 .2 ±3.2 F = 10.9;
P = 0.001
F = 12.1;
P = 0.0001∗∗
Experimental
temperature (◦C) 44.4
◦C ±2.34 2 .6 ±1.74 6 .2 ±0.94 6 .4
◦C ±1.0 F = 27.3;
P = 0.0001
F = 106.6;
P = 0.0001∗∗
Temporal
summation (Δ) 4.8 ±25.9 −2.9 ±25.11 2 .9 ±24.71 4 .9 ±29.0 F = 3.5;
P = 0.068
F = 5.0;
P = 0.008∗∗
Δ: delta, FIQ: Fibromyalgia Impact Questionnaire, FM: ﬁbromyalgia, HC: healthy controls, TPTs: thermal pain thresholds, ± refers to standard deviations.
∗missing data for a few subjects; ∗∗FM lower than 45◦C < 2 other groups (Bonferroni correction).
endogenous state of central sensitization. However, the great
majority of studies have been performed thus far in small
samples of FM patients (n ≈ 15). Although such small-scale
studiesmayhavesuﬃcientsamplesizetoexaminediﬀerences
betweenFMpatientsandhealthycontrols,theyarenotsuited
to determine the rate of FM patients who have exaggerated
windup.FMisahighlyheterogeneousdisorder,whosesymp-
toms (fatigue, pain, anxiety, depression, sleep problems,
etc.) vary considerably from one patient to another, and
the pathophysiological processes underlying these symptoms
may also vary considerably across subgroups of FM patients
[18]. In this vein, our group has gathered abundant evidence
that FM is associated with substantial heterogeneity in psy-
chophysicalpainmeasures,suchasheatpainthresholds,cold
hyperalgesia, and pain inhibition eﬃcacy [19–21]. Recently,
our group developed a paradigm using continuous thermal
noxious stimuli to measure temporal summation in humans
[13]. Using this simple and easily tolerated paradigm, the
current study sought to measure temporal summation of
heat pain in a large sample of FM patients and to determine
whethertemporalsummationishomogeneouslyincreasedin
this population.
2. Methods
2.1. Participants. Seventy-two women suﬀering from FM
and 39 healthy women participated in this study aged
between 18 and 65 years old. Patients were diagnosed with
FM using American College of Rheumatology criteria [1]b y
neurosurgeons, rheumatologists, or physicians specialized in
chronic pain. That is, FM patients all suﬀered from diﬀuse
pain lasting more than 3 months, and all had ≥11 tender
points, as determined by the tender point assessment that
was performed as part of the routine medical examina-
tion. None of the patients were referred by psychiatrists.
Participants (patients and controls) who were pregnant or
breastfeeding,whohaddiabetes,lupus,rheumatoidarthritis,
or suﬀering from a cardiac pathology were excluded from
the study. Patients and controls did not diﬀer in terms
of age and presence/absence of menstrual cycle (Table 1).
None of the FM patients were treated with opioid analgesics.
Twenty-seven FM patients received antidepressants and 17
received anticonvulsants at the moment of psychophysical
testing. The Human Ethics Committees of the Universit´ e
du Qu´ ebec en Abitibi-T´ emiscamingue and Universit´ ed eS h e r -
brooke approved the research protocol, and all participants
gave their written, informed consent.
2.2. Clinical Assessment. The symptoms of FM were assessed
using the French version of the self-administered Fibromyal-
gia Impact Questionnaire (FIQ) that measures the compo-
nents of health (pain, stiﬀness, fatigue, anxiety, depression,
physical functioning, work status, and well-being) most
aﬀected by FM over the last week [22]. The French version is
widely used by researchers and clinicians and has acceptable
internal consistency, test-retest reliability, and construct va-
lidity [23].
2.3. Experimental Pain Measures
2.3.1. Thermal Pain Thresholds. In a pretest at the begin-
ning of the session, thermal pain thresholds (TPTs) were
measured by applying a thermode on the left forearm of
participants. The Peltier thermode used (TSA II, Medoc,Pain Research and Treatment 3
Advanced medical systems, Minneapolis, MN 55435) was
a heating plate connected to a computer, which allowed a
precise setting of experimental temperature. Subjects were
advised that the thermode temperature would gradually
increase from 32◦Ct o5 1 ◦C (maximum) by a rate of 0.3◦C
per seconds until it reached their thermal pain tolerance.
During the full thermal stimulation, pain intensity was
continuouslymeasured(at1Hz)usingacomputerizedvisual
analog scale (COVAS), which ranged from 0 (no pain) to 100
(most intense pain tolerable). Subjects were also instructed
to start displacing the COVAS’ cursor when their sensations
changed from heat to pain (TPTs). For each subject, the
procedure was repeated twice to ensure the stability of
measurementoftheTPTsandtheexperimentaltemperature.
2.3.2. Temporal Summation of Heat Pain. The temporal
summationtestwascompletedafterthepretestandconsisted
of a continuous heat pulse administered with a thermode
for 2 minutes on the left forearm of participants. Exper-
imental temperature reached a predetermined ﬁxed value
and remained constant during the 2-minute testing period
(Time 0 to Time 120). It was set at a value corresponding
to a temperature individually predetermined to induce a
50/100 pain rating during the 2 pretesting sessions used to
determine the individual’s TPT. That is, during the pretests,
the experimenter noted the temperature associated with a
50/100 pain rating, as displayed on the Medoc software
(laptop), for each subject. For the temporal summation
stimulation, participants were not told that the temperature
remains constant throughout testing, after reaching the indi-
vidualized experimental temperature (Time 0). During the
thermaltemporalsummationstimulation,painintensitywas
also measured using the COVAS. Research in our laboratory
has shown that pain perception scores increase through
the 2 minutes of testing, most prominently during the
last 15 seconds, even if the thermode temperature remains
constant [13, 24], suggesting a temporal summation eﬀect.
Importantly, pain ratings at Time 0 (when the experimental
temperature is reached) were very close to 50/100 and did
not diﬀer between FM patients and healthy controls (see
Table 1).
2.4. Statistical Analyses. For statistical purposes, we used
3 dependent variables, namely, (i) TPTs, (ii) experimental
temperature, and (iii) temporal summation (Mean COVAS
scoreTime15–30s minus Mean COVAS scoreTime105–120s)[ 13].
Analyses of variance (ANOVAs) were conducted to explore
the potential diﬀerences between FM patients and healthy
volunteers. The critical level of signiﬁcance for rejecting the
null hypothesis was set at 5%.
3. Results
3.1. FM Patients versus Healthy Controls (HC). Relative to
healthy controls, FM patients (as a whole) had lower TPTs
and lower experimental temperature (Table 1). Temporal
summation of pain was also decreased in FM patients,
relative to controls, although this diﬀerence failed to achieve
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Figure 1: Temporal summation of heat pain ﬁbromyalgia patients
and healthy controls. This ﬁgure depicts the time course of
pain perception during the tonic thermal noxious stimulation in
ﬁbromyalgia (FM) patients (open circles) and healthy controls
(HCs) (black lines). We can clearly see that HCs have more pain
at the end of the curve (temporal summation) when compared to
FM patients; error bars refer to standard errors.
signiﬁcance (Table 1, Figure 1) .N o t i c e a b l y ,ap o s i t i v eP e a r -
son’s correlation was found between experimental temper-
ature and the rate of temporal summation in FM (r =
0.331; P = 0.005). Finally, none of the pain measures
signiﬁcantly diﬀered between FM patients with and without
antidepressants, as well as FM patients with and without
anticonvulsants (all P>0.05).
3.2. FM Patients (≥ or <45◦C) versus HC. Given that
FM patients required lower experimental temperatures to
achieve 50/100 pain ratings, and that it has been shown
that low-intensity nociceptive stimuli elicit less (or even
no) temporal summation than high-intensity stimuli in
healthy subjects [25], we performed secondary analyses to
determine the inﬂuence of experimental temperature on our
results. More precisely, we subdivided FM patients into those
who received thermal stimulation lower and higher than
45◦C, since 45◦C was the lowest experimental temperature
used in our sample of HC [Note: None of the controls
required an experimental temperature lower than 45◦Ct o
induce a 50/100 pain rating, thus, none needed to be
excluded on that basis]. Post hoc analyses revealed that FM
patients ≥/<45◦C and controls diﬀered in terms of TPTs
and temporal summation (Table 1, Figure 2). After applying
Bonferoni correction, multiple comparisons revealed that
FM ≥ 45
◦C patients did not diﬀer from HC in terms of
temporal summation of pain and TPTs. The FM < 45
◦C
subgroup had lower TPTs and lower temporal summation
of pain, relative to the 2 other groups. Importantly, the
experimental temperature used during the 2-minute thermal
noxious stimulation did not diﬀer between FM ≥ 45
◦C
patientsandcontrols,butitwasobviouslydecreasedinFM <
45
◦C patients, relative to the 2 other groups (Table 1). Also
noteworthy,theFIQtotalscoreandtheFIQpainitemdidnot4 Pain Research and Treatment
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Figure 2: Temporal summation of heat pain in ﬁbromyalgia
subgroups. This ﬁgure depicts the time course of pain perception
during the tonic thermal noxious stimulation in ﬁbromyalgia (FM)
patientsreceivingexperimentaltemperatureslowerandhigherthan
45◦C. We can clearly see a temporal summation eﬀect in the FM ≥
45
◦C subgroup that was not present in the FM < 45
◦C subgroup;
error bars refer to standard errors.
diﬀer between FM patients whose experimental temperature
was higher and lower than 45◦C( Table 1).
4. Discussion
As shown previously by our group and others, TPTs were
l o w e ri nF Mr e l a t i v et oH C[ 19, 21, 26, 27], suggesting that
FM may not only be associated with mechanical hyperal-
gesia but also with thermal hyperalgesia. When examining
temporal summation in a large group of FM patients, we
found decreased temporal summation of pain in FM, relative
to HC. However, the experimental temperatures used in
the FM group as a whole were signiﬁcantly lower than the
temperatures used in controls, meaning that both groups did
not receive noxious heat stimulations of similar intensities.
To overcome this methodological limitation, FM patients
were subdivided into those receiving thermal stimulations
higher and lower than 45◦C. Importantly, we found that the
group receiving stimulations higher than 45◦C did not have
increased temporal summation of pain, relative to controls,
despite equivalent thermal stimulation intensities. This latter
resultstronglysuggeststhatalargeproportionofFMpatients
(here, 35 out of 72) do not have overactive endogenous
excitatory pain mechanisms, a result which is unequivocally
inconsistent with repeated ﬁndings from other groups [14–
17]. As such, this ﬁnding deserves greater consideration.
One possible explanation for the lack of increased or
even lack of temporal summation of pain in FM is that
we only included female patients in our study, whereas
most previous studies on the topic included both male and
female participants [14–17]. However, this factor is unlikely
to explain the discrepancy between our results and previous
ones, because increased temporal summation of pain has
been shown in both male and female FM patients [14–17].
Anotherpotentialreasonmaylieinthefactthatweemployed
a temporal summation paradigm using continuous heat
stimuli instead of repetitive heat pulses, as used previously
by other groups [14–17]. However, this factor is also unlikely
to explain per se the discrepancy between our results and
previous ones, because an experimental study by Granot and
colleagues[28]directlycomparedbothproceduresinhealthy
subjects and found that phasic and tonic stimuli produce
similar temporal summation eﬀects. Still, by employing
repetitive heat pulses of short durations (∼1sec), researchers
arehabituallyabletouseelevatedthermalstimuli(range:47–
51◦C) to induce temporal summation of pain in FM patients
[14, 15, 17], something that was diﬃcult to achieve here, in
a subgroup of FM patients, by using tonic stimuli lasting 2
minutes. In a closely related matter, it must be considered
that in our study, individualized experimental temperatures
were used, whereas previous groups used ﬁxed temperatures
in most cases [14, 15, 17]. That is, all participants (FM
patient and controls) received identical noxious stimuli
in the previous ﬁxed-temperature protocols, whereas FM
patients received lower thermal stimulations, compared to
controls, in our individualized-temperature protocol. Since
FM patients had lower TPTs in our study, some FM patients
expectedly required lower experimental temperatures to
achieve 50/100 pain ratings. This may explain why FM
patients (as a whole) had decreased (nonsigniﬁcant trend)
temporal summation of pain, relative to controls. It may
also explain why there was no temporal summation eﬀect at
all in the FM < 45
◦C subgroup. Indeed, the experimental
temperatures that this subgroup of patients could tolerate
were probably too low (e.g., 42.6◦C) to induce signiﬁcant
thermal windup. As such, this observation shows that the
use of individualized experimental temperatures may be
problematic when studying thermal pain windup in some
chronic pain patients who are particularly hypersensitive to
thermal pain.
We acknowledge that these methodological diﬀerences
(continuous stimuli, individualized temperatures) between
our procedure and the procedures used previously by other
labs may explain the discrepancy of the results obtained in
the FM < 45
◦C patients. However, the critical issue here is
that these diﬀerences cannot rule out the main ﬁnding of our
study, namely, that a large subgroup of FM patients do not
have increased temporal summation of heat pain. Despite
the fact that the experimental temperatures used in the
FM ≥ 45
◦C patients and the controls were nearly identical
(46.2 versus 46.4◦C, resp.), the FM ≥ 45
◦Cs u b g r o u p
did not display enhanced temporal summation of pain,
relative to controls. That is, despite the use of suﬃciently
noxious stimuli (≥45◦C) to induce temporal summation,
pain ampliﬁcation was normal in large proportion of FM
patients (close to 50/100). This raises the possibility that
previous studies were not able to demonstrate the existence
of this large subgroup of FM patients because they had
very small samples of patients, clearly underpowered to
detect subgroup eﬀects and not designed to do so. Moreover,
using a ﬁxed temperature rather than a temperature adjusted
to pain perception may be problematic. For the same
stimulation intensity, the perceived pain is signiﬁcantly
higher in FM patients. This augmented perception may bePain Research and Treatment 5
the sole explanation for the increased temporal summation.
The augmentation of the healthy subjects’ experimental
temperatures to the perceived pain of FM patients may have
further increased the level of temporal summation of heat
pain observed in these subjects.
Intriguingly, both FM subgroups did not diﬀer in FIQ
total and FIQ pain scores. Although the exact meaning
of this result remains elusive, it may suggest that thermal
pain hypersensitivity, as displayed by the FM < 45
◦C
subgroup, is not a pathognomonic feature of FM, since the
FM ≥ 45
◦C patients had signiﬁcant levels of FM symptoms
without having signiﬁcantly reduced TPTs, relative to HC.
Apart from the well-described mechanical allodynia, other
pain mechanisms could be altered in these FM patients,
including deﬁcient endogenous pain inhibition, autonomic
dysfunctions, enhanced appraisal of pain, and/or abnormal
inﬂammatory responses [29]. Further studies on the hetero-
geneity of altered pain mechanisms in FM are required.
Overall, our results strikingly cast some doubt on the
whole idea that endogenous excitatory pain mechanisms are
overactive in the great majority of FM patients. However, it
is important to be cautious when interpreting our results,
s i n c ew ec a n n o tr u l eo u tt h a tt e m p o r a ls u m m a t i o nm a y
have emerged as signiﬁcantly increased in the FM < 45
◦C
subgroup if we had used another temporal summation
procedure. Indeed, pain ampliﬁcation has been repeatedly
reported to be more pronounced in FM patients, relative
to healthy controls, in seminal studies performed by other
groups using ﬁxed experimental temperatures [14–17].
Moreover, our own study comprised a large subgroup of
FM patients (n = 37) having very low TPTs, who all had
experimental temperatures lower than 45◦C, suggesting that
this subgroup of FM patients was already sensitized to pain
from the very start of thermal stimulations. Using ﬁxed-
temperature noxious stimuli to elicit temporal summation,
it seems possible that we may have found this subgroup
to have increased temporal summation of pain, relative to
controls. If lower experimental temperatures are required
to elicit 50/100 pain ratings in the FM < 45
◦Cs u b g r o u p ,
it seems likely that ﬁxed temperatures across groups would
have been rated as more painful in the FM < 45
◦C
patients, relative to controls. Head-to-head comparisons
of temporal summation paradigms using repetitive versus
continuous thermal stimuli as well as individualized and
ﬁxed temperatures will need to be performed in large
samples of FM patients in order to verify this assumption.
Although the temporal summation results of the FM <
45
◦C subgroup must be taken cautiously for obvious
methodologicalreasons,thelackofincreasedpainampliﬁca-
tion in the subgroup of FM patients who received signiﬁcant
levels of tonic thermal noxious stimuli (≥45◦C) has to be
taken seriously. As such, this latter result may have decisive
implications for the identiﬁcation of FM subgroups and the
characterization of underlying physiopathological processes.
For instance, the ﬁnding of increased pain ampliﬁcation
in FM has prompted the hypothesis that glutamatergic
disturbances may be involved in the physiopathology of
FM [3]. The results of the current study suggest that this
hypothesis will need to be examined in FM while bearing
in mind that FM is not a homogeneous syndrome, both
clinically and physiologically.
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